Overview
My research innovatively integrates gnotobiotic murine models, immunology, microbiology, and characterization of the microbiota with the ultimate aim of identifying specific commensal bacteria with immunomodulatory potential and subsequent characterization of their biologic effects. We have recently developed an inventive approach for identifying with high specificity organisms within the microbiota that are causally related to the phenotype of interest. Using this approach of microbe–phenotype triangulation, we identified Clostridium immunis, a new bacterial species that protects against colitis in murine models, and two bacterial species that induce host expression of a critical antimicrobial peptide. We are now investigating the molecular mechanisms—from both the bacterial and host perspectives—that underlie these host–commensal relationships. Furthermore, we are extending our discovery platform to human samples and additional disease processes to identify more causal microbes.
Current Appointments & Affiliations
Assistant Professor of Pediatrics
·
2018 - Present
Pediatrics, Infectious Diseases,
Pediatrics
Assistant Professor in the Department of Molecular Genetics and Microbiology
·
2018 - Present
Molecular Genetics and Microbiology,
Basic Science Departments
Assistant Professor of Integrative Immunobiology
·
2019 - Present
Integrative Immunobiology,
Basic Science Departments
Assistant Professor of Cell Biology
·
2022 - Present
Cell Biology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2022 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Impact of fiber-containing enteral nutrition on microbial community dynamics in critically ill trauma patients: a pilot-randomized trial.
Journal Article BMC Med · December 29, 2025 BACKGROUND: Gut microbial dysbiosis is common in the intensive care unit and certain derangements, like expansion of Enterobacteriaceae and other potential pathogens (pathobionts), are associated with increased morbidity. In other populations, dysbiosis is ... Full text Link to item CiteDecreased Microbiota-Driven Tyrosine Metabolism Is Associated With Symptomatic COVID-19 in Children.
Journal Article J Infect Dis · October 15, 2025 BACKGROUND: The gut microbiota has been implicated in driving coronavirus disease 2019 (COVID-19) disease severity, but the underlying mechanisms remain unknown. We investigated the relationship between the gut microbiota and development of symptomatic COV ... Full text Link to item CiteA commensal-derived sugar protects against obesity by regulating immunometabolism.
Preprint · September 18, 2025 Full text Link to item CiteRecent Grants
Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEProgram Leader · Awarded by National Institutes of Health · 2010 - 2030Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of Allergy and Infectious Diseases · 2018 - 2029Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027View All Grants
Education, Training & Certifications
Washington University, School of Medicine ·
2006
M.D.
Washington University in St. Louis ·
2006
Ph.D.